T1	Concept 5 9	AIPs
T2	Concept 36 41	drugs
T3	Action 15 23	targeted
R1	subject Arg1:T3 Arg2:T2	
R2	target Arg1:T3 Arg2:T1	
T4	Concept 55 106	heat shock protein 90 alpha family class A member 1
T5	Concept 108 116	HSP90AA1
*	same-as T5 T4
T6	Concept 122 143	tumor necrosis factor
T7	Concept 145 148	TNF
*	same-as T6 T7
R3	is-a Arg1:T4 Arg2:T1	
R4	is-a Arg1:T6 Arg2:T1	
T8	Concept 167 172	small
T9	Concept 173 180	changes
T10	Reference 150 155	These
R5	has-property Arg1:T9 Arg2:T8	
R6	is-a Arg1:T10 Arg2:T9	
T11	Concept 188 206	subunit structures
R7	in-place Arg1:T9 Arg2:T11	
T12	Concept 229 235	shifts
T13	Concept 222 228	larger
R8	has-property Arg1:T12 Arg2:T13	
T14	Concept 243 250	hexamer
R9	in-context Arg1:T12 Arg2:T14	
R10	entails Arg1:T10 Arg2:T12	
T15	Concept 258 262	half
T16	Concept 266 274	patients
R11	in-context Arg1:T15 Arg2:T16	
T17	Concept 282 291	increased
T18	Concept 292 298	levels
T19	Concept 302 305	LDH
R12	has-property Arg1:T18 Arg2:T17	
R13	in-context Arg1:T18 Arg2:T19	
R14	in-place Arg1:T18 Arg2:T15	
T20	Concept 313 322	one-third
T21	Concept 326 334	patients
T22	Concept 344 356	liver injury
T23	Concept 361 370	decreased
T24	Concept 371 377	levels
R15	in-context Arg1:T20 Arg2:T21	
R16	in-place Arg1:T22 Arg2:T20	
T25	Concept 381 391	prealbumin
R17	has-property Arg1:T24 Arg2:T23	
R18	in-context Arg1:T24 Arg2:T25	
R19	in-place Arg1:T24 Arg2:T20	
T26	Action 446 455	reduction
T27	Concept 437 445	mobility
R20	target Arg1:T26 Arg2:T27	
T28	Action 478 483	lower
T29	Concept 466 477	effectively
A1	Negated T29
R21	has-property Arg1:T28 Arg2:T29	
T30	Concept 488 502	incidence rate
R22	target Arg1:T28 Arg2:T30	
R23	subject Arg1:T28 Arg2:T26	
T31	Concept 509 512	50%
T32	Action 534 543	reduction
T33	Concept 513 529	transmissibility
R24	target Arg1:T32 Arg2:T33	
R25	in-context Arg1:T32 Arg2:T31	
T34	Action 557 564	prevent
A2	Emphasized T34
A3	Uncertain T34
T35	Action 592 601	spreading
T36	Concept 569 578	epidemics
R26	subject Arg1:T35 Arg2:T36	
R27	target Arg1:T34 Arg2:T35	
R28	subject Arg1:T34 Arg2:T32	
